4.3 Article

LncRNA H19 confers chemoresistance in ERα-positive breast cancer through epigenetic silencing of the pro-apoptotic gene BIK

Journal

ONCOTARGET
Volume 7, Issue 49, Pages 81452-81462

Publisher

IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.13263

Keywords

breast cancer; chemoresistance; lncRNA H19; apoptosis; estrogen receptor

Funding

  1. National Natural Science Foundation of China [81172091, 81301897]
  2. Open Foundation of State Key Laboratory of Pharmaceutical Biotechnology of Nanjing University
  3. College Postgraduates Innovative Research Plan of Jiangsu Province [CXZZ13_0561]

Ask authors/readers for more resources

Breast cancer is a common malignancy in women. Acquisition of drug resistance is one of the main obstacles encountered in breast cancer therapy. Long non-coding RNA (lncRNA) has been demonstrated to play vital roles in both development and tumorigenesis. However, the relationship between lncRNAs and the development of chemoresistance is not well established. In the present study, the high expression of lncRNA H19 was identified as a powerful factor associated with paclitaxel (PTX) resistance in ER alpha-positive breast cancer cells, but not in ER alpha-negative breast cancer cells. LncRNA H19 attenuated cell apoptosis in response to PTX treatment by inhibiting transcription of pro-apoptotic genes BIK and NOXA. H19 was further confirmed to suppress the promoter activity of BIK by recruiting EZH2 and by trimethylating the histone H3 at lysine 27. Interestingly, our data showed that lncRNA H19 was one of the downstream target molecules of ER alpha. Altered ERa expression may therefore change H19 levels to modulate the apoptosis response to chemotherapy in breast cancer cells. Our data suggest that the ER alpha-H19-BIK signaling axis plays an important role in promoting chemoresistance.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available